Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 10,000 shares at $23.26 ($233K) on 2019-09-03, disclosed to the SEC on 2019-09-05.
Open-market sale of $233k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.26 | 5,000 | $116K | 50.0% |
| 2 | $23.26 | 5,000 | $116K | 50.0% |
| Total | $23.26 avg | 10,000 | $233K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |